A broad molecular characterization of MAPK/ERK, PIK3CA, and JAK/STAT pathway genes and gene fusions, including NTRK fusions, seems advisable in rare JXG cases with severe disseminated skin disease, extracutaneous manifestation with clinical complications and systemic disease. The gene discussed is PIK3CA; the disease is juvenile xanthogranuloma.